{"id":"W2070286579","doi":"10.1038/nrurol.2010.65","title":"Pazopanib trial data cannot support first-line use","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pazopanib; Medicine; Sunitinib; Tolerability; Everolimus; Oncology; Renal cell carcinoma; Internal medicine; Randomized controlled trial; Clinical trial; Urology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.001837962,0.00136704,0.008460196,0.0004313765,0.0001066196,0.00005064787,0.001481693,0.00468216,0.001146997],"category_scores_gemma":[0.003260045,0.0008502681,0.001556586,0.0006139984,0.0001860799,0.0001545253,0.0007530533,0.007430908,0.001491892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002411249,"about_ca_system_score_gemma":0.001365644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003784118,"about_ca_topic_score_gemma":0.0002821161,"domain_scores_codex":[0.9932526,0.000863064,0.00238581,0.002059058,0.0005563917,0.0008830721],"domain_scores_gemma":[0.9908402,0.0008521225,0.001438839,0.00615847,0.0001762361,0.000534109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001239056,0.0003082345,0.000008395106,0.01387355,0.0003514813,0.001174693,0.000005174688,1.306987e-8,2.574707e-7,0.00005132764,0.05297479,0.930013],"study_design_scores_gemma":[0.007945645,0.001706746,0.000005889406,0.002536426,0.01322209,0.004204293,1.544118e-7,0.000001377756,3.418687e-7,0.000006721345,0.9698374,0.000532947],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000005463562,0.9841985,0.000007582106,0.0006885515,0.003382681,0.00975406,0.0006303923,0.00009785283,0.001234889],"genre_scores_gemma":[0.000005267993,0.9750667,0.0006778259,0.001774887,0.003850197,0.000632426,0.01499343,0.0002088402,0.002790439],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9294801,"threshold_uncertainty_score":0.999908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2087111433693524,"score_gpt":0.423913462430458,"score_spread":0.2152023190611055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}